ASX:SGH News 6 January 2026

New Zealand Stock Market Ends Higher as BlueScope Bid Sparks Steel Rally, Infratil Gains

New Zealand’s S&P/NZX 50 index rose 0.56% to 13,663.58 Tuesday, led by steel and construction stocks after a takeover bid for Australia’s BlueScope Steel. Vulcan Steel jumped 3.6%, Steel & Tube 4.7%, and Fletcher Building 1.6%. BlueScope surged 21% in Sydney after receiving a buyout proposal from SGH and Steel Dynamics. Banks fell, with Westpac and ANZ both down 2.6%.

6 January 2026

ASX:BSL·ASX:SGH·NYSE:STLD·NZX:AIA·NZX:FBU·NZX:FPH·NZX:IFT·NZX:STU·NZX:VSL·Stock Market

ASX 200 drops on bank selloff as BlueScope jumps on $13.15 bln bid; inflation data next

S&P/ASX 200 fell 0.52% to 8,682.8, marking its weakest session in three weeks as major banks dropped 2%–3% ahead of key inflation data. BlueScope soared 21% after receiving a A$13.15 billion takeover approach from SGH and Steel Dynamics. Miners closed at a record high. Silex Systems plunged about 33%.

6 January 2026

ASX:BSL·ASX:CBA·ASX:SGH·Inflation·NYSE:STLD·Stock Market

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

7 February 2026

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026

AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

7 February 2026

Wells Fargo shares rose 2.63% to $93.97 Friday as U.S. stocks rebounded. The stock traded ex-dividend for a $0.45 payout due March 1. Investors await delayed U.S. jobs and inflation data next week and a scheduled CFO appearance at a bank conference.

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

7 February 2026

Merck shares closed up 1.8% at $121.93 Friday after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140. Insider filings showed three executives sold shares this week. Merck’s stock ended just below its 52-week high, with about 13 million shares traded.

ASX:SGH News 6 January 2026

New Zealand Stock Market Ends Higher as BlueScope Bid Sparks Steel Rally, Infratil Gains

ASX 200 drops on bank selloff as BlueScope jumps on $13.15 bln bid; inflation data next

Stock Market Today

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

AstraZeneca stock price: What could move AZN next week as earnings loom

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface